Filter Results:
(2,525)
Show Results For
- All HBS Web
(5,300)
- People (16)
- News (1,939)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Show Results For
- All HBS Web
(5,300)
- People (16)
- News (1,939)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Sort by
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- 22 Apr 2002
- Research & Ideas
Profits and Prophets: The Role of Values in Investment
provided a good return for a pension fund holder at some point, but that investor and society pay more in the end through increased health care costs. Hayes said that Domini's picture of a system run amok,... View Details
Keywords: by Sean Silverthorne
- 25 Feb 2015
- Lessons from the Classroom
Scholars and Students Unpack the Digital Business Revolution
article The Capitalist's Dilemma.) More recently, HBS's Health Care and Digital initiatives collaborated on the Health Acceleration Challenge to identify proven innovations... View Details
- November 2009 (Revised August 2010)
- Case
NovoCure Ltd.
By: William A. Sahlman and Sarah Flaherty
Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor... View Details
Keywords: Financial Crisis; Entrepreneurship; Venture Capital; Investment; Health Care and Treatment; Health Testing and Trials; Technological Innovation; Financial Services Industry
Sahlman, William A., and Sarah Flaherty. "NovoCure Ltd." Harvard Business School Case 810-045, November 2009. (Revised August 2010.)
- September 2008 (Revised March 2020)
- Supplement
Medtronic: Patient Management Initiative (B)
The (B) case provides the denouement to the (A) case about Medtronic's introduction of the Chronicle and remote monitoring business. View Details
Keywords: Health Care and Treatment; Measurement and Metrics; Information Technology; Competitive Strategy; Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medtronic: Patient Management Initiative (B)." Harvard Business School Supplement 309-064, September 2008. (Revised March 2020.)
- November 1978 (Revised February 1990)
- Case
Amicon Corp. (C)
Details the negotiations between Amicon and one potential licensee, Jackson. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Capon, Noel. "Amicon Corp. (C)." Harvard Business School Case 579-095, November 1978. (Revised February 1990.)
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
facilitate the efforts of professionals there by decreasing the time required per case. It provides a good solution where expertise is limited if no one has significant thoracic experience, for example. It creates the potential for institutional interaction, too. This... View Details
- March 17, 2017
- Article
How Economics Can Shape Precision Medicines
By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
Many public and private efforts in coming years will focus on research in precision medicine, developing biomarkers to indicate which patients are likely to benefit from a certain treatment so that others can be spared the cost—financial and physical—of being treated... View Details
Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "How Economics Can Shape Precision Medicines." Science 355, no. 6330 (March 17, 2017): 1131–1133.
- 13 Jul 2022
- Book
Reimagining the Economy: What Would It Take to Put People First?
harshest months of the lockdown. The level of control Sandra and her coworkers have over their working conditions may sound like a reasonable baseline for all workers. Indeed, access to dignified work, democratized governance, and a job that View Details
Keywords: by Avery Forman
- August 2021
- Teaching Note
IBM Watson at MD Anderson Cancer Center
By: Shane Greenstein and Mel Martin
Teaching Note for HBS Case No. 621-022. View Details
Keywords: Decision Making; Technological Innovation; Innovation Strategy; Knowledge Management; Knowledge Use and Leverage; Operations; Failure; Information Technology; Applications and Software; Health Care and Treatment; Product Development; Health Industry; Health Industry; Health Industry; United States; Houston; Texas
- 05 Jul 2006
- First Look
First Look: July 5, 2006
MaterialsAncora: A Private University in the Health Care of the Poor 306-088 Project Ancora signals the entry of the private sector into primary healthcare for Chile's poor. On a commercial basis, it seeks... View Details
Keywords: Sean Silverthorne
- 09 Jul 2008
- Research & Ideas
Starbucks’ Lessons for Premium Brands
coffee, revitalizing the quality of its standard beverages. But none of these moves addressed the fundamental problem: Starbucks is a mass brand attempting to command a premium price for an experience that is no longer special. Either you... View Details
- 29 Jul 2008
- First Look
First Look: July 29, 2008
situation facing Gary Gottlieb, president of Brigham and Women's Hospital (BWH), prior to the opening of BWH's integrated cardiovascular center. This case allows students to develop an appreciation of the strategic, financial, organizational, clinical, and physical... View Details
Keywords: Martha Lagace
- 23 Jan 2012
- Research & Ideas
Break Your Addiction to Service Heroes
that there are a lot of heroic people in service organizations who feel compelled to be the best at everything. That's particularly evident in mission-driven and health care organizations, where managers... View Details
- 23 May 2011
- Research & Ideas
Corporate Sustainability Reporting: It’s Effective
change in the social awareness of investors in the past decade. "The number of investors who care about this kind of performance has increased dramatically in the last 10 years," Serafeim says. "Right now those investors have about $5... View Details
Keywords: by Michael Blanding
- June 2000
- Case
Lifeline Systems, Inc. (A)
By: H. Kent Bowen and Marilyn Matis
Lifeline Systems provides emergency response equipment to the elderly who live at home. The company uses local hospitals to market, sell, and install these units in homes, while the hospital monitors and calls for aid to respond to emergency calls from the elderly... View Details
Keywords: Health Care and Treatment; Product Marketing; Sales; Problems and Challenges; Growth and Development Strategy; Managerial Roles; Service Operations; Information Infrastructure; Age; Service Delivery; Restructuring; Crisis Management; Health Industry; Health Industry
Bowen, H. Kent, and Marilyn Matis. "Lifeline Systems, Inc. (A)." Harvard Business School Case 600-099, June 2000.
- March 2014
- Teaching Note
Uptake of Rapid Diagnostic Tests: A Development Challenge
By: Nava Ashraf, Andrew Boozary and Kristin Johnson
Keywords: Developing Countries and Economies; Health Pandemics; Technology; Health Care and Treatment; Policy; Behavior; Prejudice and Bias; Zambia
Ashraf, Nava, Andrew Boozary, and Kristin Johnson. "Uptake of Rapid Diagnostic Tests: A Development Challenge." Harvard Business School Teaching Note 914-042, March 2014.
- 14 May 2013
- First Look
First Look: May 14
P/E industries, which have a negative valuation change in the year after the investment. 2006 New England Journal of Medicine Leading Clinicians and Clinicians Leading By: Bohmer, Richard M.J. Abstract—More effective models of care... View Details
Keywords: Sean Silverthorne
- July 2019
- Article
The Impact of Price Regulation on the Availability of New Drugs in Germany
By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
- January–February 2021
- Article
Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses
By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
As pressure mounts on the Food and Drug Administration (FDA) to speed its review process for novel devices, and budgetary pressures further strain its resources, the critical role of guidance documents in assuring consistent, rigorous, and scientifically grounded... View Details
Keywords: Medical Devices; FDA; Health Care and Treatment; Government Administration; Information; Standards
Weitzman, Rachel E., Ariel Dora Stern, and Daniel B. Kramer. "Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses." American Journal of Therapeutics 28, no. 1 (January–February 2021).